Physician profile
Timothy Spires
NPI 1346257870
$5,251.93
in general payments reported to CMS, 2019-2025
13 companies · $1,924 in 2025
The $1,924 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,121 · 2020: $1,535 · 2021: $70.98 · 2022: $136 · 2023: $200 · 2024: $265 · 2025: $1,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255 · Travel and Lodging: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.66 |
| Travel and Lodging | $1,134.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $1,578.22 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,561.36 | 2025 | Oxford |
| Stryker Corporation | $1,206.79 | 2019-2025 | Axsos, T2 |
| Amgen INC. | $419.68 | 2019-2020 | |
| Horizon Therapeutics Plc | $218.54 | 2019 | |
| Depuy Synthes Sales INC. | $86.95 | 2019-2023 | Fibergraft Aeridyan Matrix |
| Medtronic USA, INC. | $55.76 | 2019 | |
| Bioventus LLC | $34.98 | 2024 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $29.28 | 2020-2021 | |
| Ethicon US, LLC | $20.71 | 2022 | |
| Endo Pharmaceuticals INC. | $13.78 | 2019 | |
| Fidia Pharma USA INC. | $13.22 | 2019 | |
| Pfizer INC. | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Spires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.